SIRT4 as a novel interactor and candidate suppressor of C-RAF kinase in MAPK signaling

Area of Science:

• Cellular signaling
• Molecular biology
• Oncology

Background:

• The RAF/MEK/ERK pathway is crucial for cell development, proliferation, and differentiation.
• Dysregulation of this pathway, particularly C-RAF activation, is implicated in tumor proliferation and developmental disorders.
• Identifying regulators of C-RAF is essential for therapeutic strategies.

Purpose of the Study:

• To identify novel protein regulators of C-RAF.
• To investigate the interaction between C-RAF and members of the sirtuin family.
• To elucidate the functional consequences of C-RAF and SIRT4 interaction on cellular signaling.

Main Methods:

• Protein-protein interaction studies to identify binding partners of C-RAF.
• Structural analysis to determine the binding domains between C-RAF and SIRT4.
• Cellular assays (HEK293 cells) to assess the impact of SIRT4 expression on C-RAF phosphorylation and MAPK signaling.

Main Results:

• A specific interaction was identified between C-RAF and SIRT4.
• SIRT4 binds to the N-terminal domain of C-RAF, while SIRT4's C-terminus is crucial for interaction.
• SIRT4 specifically binds to the inactive, serine 259-phosphorylated state of C-RAF.
• SIRT4 expression increases pS259-C-RAF levels and reduces MAPK signaling (decreased phospho-ERK).

Conclusions:

• SIRT4 interacts with C-RAF in its pre-signaling inactive state.
• SIRT4 functions as a cytosolic tumor suppressor by inhibiting C-RAF-MAPK signaling.
• This represents an additional role for SIRT4 beyond its known mitochondrial metabolic functions.